Cargando…
Cognition comes of age: comments on the new FDA draft guidance for early Alzheimer’s disease
BACKGROUND: The FDA have recently published draft guidance for the development of treatments for early Alzheimer’s disease. Key features of this guidance are the advocacy of sensitive cognitive measures and a taxonomy of disease severity. Whilst desirable patterns of cognitive-functional improvement...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6026341/ https://www.ncbi.nlm.nih.gov/pubmed/29958538 http://dx.doi.org/10.1186/s13195-018-0386-7 |